Back to Authors

Cimbora, D.

A5112952777 | I1320553840

Mayo Clinic

Amgen (United States)

Citations 3

Efficacy and safety of inebilizumab in patients aged 50 years and older with neuromyelitis optica spectrum disorder: N-MOmentum study subgroup analysis

Arquivos de Neuro-Psiquiatria | October 11, 2024 | Volume: 82 | Issue: S 01 | Pages: S1-S52

10.1055/s-0044-1789431

Serum Neurofilament Light Chain Levels (sNfL) Correlate Best with Attack-related Disability in Neuromyelitis Optica (4105)

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.4105

Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension (3998)

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.3998